Skip to main content

Artificial Intelligence System for Multi-Cancer Detection Support

Project description

A highly accurate diagnostic tool for detecting the earliest stages of cancer

Cancer patient survival is strongly associated with the stage of disease progression at the time of diagnosis. Romanian start-up company Artificial Intelligence Expert (AIE) develops solutions to facilitate the early diagnosis and screening for various types of cancers. AIE focuses on the transition to liquid biopsies, microarray, and next-generation sequencing (NGS) for molecular diagnostics. The technology detects cancer at the earliest stages using circulating microRNAs instead of the currently used circulating tumor DNA or cancer cells. The earliest detection of cancer progression is highly accurate and employs artificial intelligence to analyse microRNA profiles from microarray and NGS data. The EU-funded AI-MICADIS project enables the company to identify partnerships and optimise the best business strategy to bring the technology to the market.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 50 000,00
Strada Alexandru Vlahuta, Bloc Lama C, Ap.45
400310 Cluj Napoca

See on map

Macroregiunea Unu Nord-Vest Cluj
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 21 429,00